Akebia Ther Cash Flow-to-Debt Ratio
Akebia Ther cash flow-to-debt ratio. Akebia Ther (AKBA) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of $31.13 Million could theoretically repay 0% of its total liabilities ($343.95 Million) in one year. Check Akebia Ther (AKBA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Akebia Ther (2012–2025)
Cash flow-to-debt ratio of Akebia Ther from 2012 to 2025. Historical debt coverage capacity for Akebia Ther across 14 annual periods. Check Akebia Ther (AKBA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Akebia Ther Cash Flow-to-Debt Ratio by Year (2012–2025)
Akebia Ther cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Akebia Ther. For the full cash flow conversion analysis, see AKBA operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $67.99 Million | $343.95 Million | ▲ +231.2% |
| 2024 | -0.15x | $-40.66 Million | $269.86 Million | ▼ -75.4% |
| 2023 | -0.09x | $-23.38 Million | $272.29 Million | ▲ +58.8% |
| 2022 | -0.21x | $-73.15 Million | $350.82 Million | ▲ +62.5% |
| 2021 | -0.56x | $-252.97 Million | $455.34 Million | ▼ -99.6% |
| 2020 | -0.28x | $-110.39 Million | $396.52 Million | ▲ +59.3% |
| 2019 | -0.68x | $-257.44 Million | $376.44 Million | ▼ -153.0% |
| 2018 | -0.27x | $-97.49 Million | $360.61 Million | ▼ -17.9% |
| 2017 | -0.23x | $-56.16 Million | $244.92 Million | ▼ -191.9% |
| 2016 | 0.25x | $57.91 Million | $232.10 Million | ▲ +105.7% |
| 2015 | -4.39x | $-52.41 Million | $11.94 Million | ▼ -10.5% |
| 2014 | -3.97x | $-27.48 Million | $6.92 Million | ▼ -37.1% |
| 2013 | -2.90x | $-11.33 Million | $3.91 Million | ▼ -97.9% |
| 2012 | -1.46x | $-7.21 Million | $4.92 Million | — |